Oculis Pharmaceuticals
Global biopharmaceutical company developing breakthrough treatments for ophthalmic and neuro-ophthalmic conditions.
About
Technology stack
detected 2026-06-22No comments yet. Be the first to share your take.
What does Oculis Pharmaceuticals do?
Oculis is a global biopharmaceutical company (Nasdaq: OCS) focused on developing treatments for ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs. The company's proprietary OPTIREACH® formulation technology enables eye drops to effectively reach the back of the eye. Its late-stage clinical pipeline includes Privosegtor (FDA Breakthrough Therapy Designation for optic neuritis), OCS-01 in pivotal studies for diabetic macular edema, and Licaminlimab for dry eye disease…
Where is Oculis Pharmaceuticals headquartered?
Oculis Pharmaceuticals is headquartered in Zug, Switzerland.
When was Oculis Pharmaceuticals founded?
Oculis Pharmaceuticals was founded in 2017.
What industry does Oculis Pharmaceuticals operate in?
Oculis Pharmaceuticals operates in Biotechnology, Pharmaceuticals, Ophthalmology, Drug Development, HealthTech, Biopharmaceuticals.